JOHNSON & JOHNSON — Director's Dealing 2026

Feb 23, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2026-02-20

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-20	Common Stock	S	1322	$245.66	Disposed	25447	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	46	Indirect
Common Stock	745	Indirect

Footnotes

F1: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).

F2: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).